Neurolentech signs technology access partnership with Kaerus Bioscience to advance neurodevelopmental disorder research

FHS
April 22, 2024
12:54 pm

Kaerus Bioscience will access Neurolentech’s NDD Drug Discovery Platform to support development of its preclinical asset pipeline for numerous genetic syndromes.

Study confirms no causal link between COVID-19 and ischemic priapism

A study in the International Journal of Impotence Research found no causal link between COVID-19 and ischemic priapism, with priapism occurring across all COVID-19 severity

June 13, 2024

Family Physicians with Value-Based Payment Models Relieve Burnout

What You Should Know: – Independent research reveals family physicians with 75% revenue derived from value-based payment models decrease burnout symptoms, according to a new

October 26, 2023

Threads May Not Replace Twitter in Medicine — Yet

Despite a promising launch, Threads — the social media app that hopes to unseat Twitter as a dominant space for online medical networking and communication

July 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.